or Try an Advanced Search...

    Kidney Disease Stocks List

    Symbol Grade Name % Change
    CTSO C Cytosorbents Corporation 9.15
    RMTI C Rockwell Medical, Inc. 6.15
    TVTX B Travere Therapeutics, Inc. -1.86
    SNY B Sanofi -1.08
    View As Page of Charts
    Related Industries: Biotechnology Data Storage Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
    Related Stock Lists: Medicine Biopharmaceutical Chronic Kidney Disease Clinical Medicine Dialysis Membrane Technology Phosphates Renal Dialysis Acid Acute Respiratory Distress Syndrome Adjunctive Therapy Animal Health Blood Plasma Blood Products Bypass Bypass Surgery Cac 40 Cancer Cardiopulmonary Bypass Cardiopulmonary Bypass Surgery

    Related ETFs - A few ETFs which own one or more of the above listed Kidney Disease stocks.

    Symbol Grade Name Weight
    VIRS A Pacer BioThreat Strategy ETF 5.06
    PPH C Market Vectors Pharmaceutical ETF 5.0
    PINK B Simplify Health Care ETF 4.96
    PID A PowerShares Intl Dividend Achievers 3.19
    BBP B BioShares Biotechnology Products Fund 2.73
    View all Kidney Disease ETFs...
    Compare ETFs
    Compare PID to BBP Compare VIRS to BBP Compare VIRS to PPH

        Kidney Disease Stocks Recent News

        Date Stock Title
        Sep 20 SNY Sanofi eyes approval after MS therapy slows disease progression by 31%
        Sep 20 SNY Sanofi's Tolebrutinib Delays Disability Progression In Patients With Multiple Sclerosis, Data Shows
        Sep 20 SNY Press Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old
        Sep 20 SNY Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old
        Sep 20 SNY Novo sinks on obesity drug results; Sanofi reveals anticipated MS data
        Sep 20 SNY Sanofi's Multiple Sclerosis Drug Slows Disability Progression in Phase 3 Study
        Sep 20 SNY Sanofi's tolebrutinib drug delays progressive MS by 31% in trial
        Sep 20 SNY Press Release: Tolebrutinib demonstrated a 31% delay in time to onset of confirmed disability progression in non-relapsing secondary progressive multiple sclerosis phase 3 study
        Sep 19 SNY Sanofi Stock Up Almost 23% in 3 Months: Buy, Sell or Hold?
        Sep 18 RMTI Rockwell Medical Stock Surges 108.5% YTD: Should You Snap it Up Now?
        Sep 18 SNY AZN Gets FDA Nod for Fasenra Label Expansion in Rare Disease
        Sep 18 RMTI Rockwell Medical Named a Fortune 'Best Workplaces in Manufacturing & Production'
        Sep 17 SNY Sanofi begins shipping BEYFORTUS to US for RSV prevention in infants
        Sep 16 SNY Why Novavax is Gaining Ground in COVID-19 Vaccine Race
        Sep 16 SNY Regeneron, SNY Win FDA Approval for a Broader Dupixent Label
        Sep 16 SNY Sanofi: Information concerning the total number of voting rights and shares - August 2024
        Sep 16 SNY Sanofi readies to meet US demand for RSV antibody
        Sep 16 SNY Sanofi shipping BEYFORTUS® in US to help protect babies against RSV disease; new manufacturing line approved by FDA
        Sep 16 SNY Hope remains that Roche’s prasinezumab can overcome recent string of failures in Parkinson’s disease
        Sep 15 RMTI Rockwell Medical: The Turnaround Is Looking Real
        Related Industries: Biotechnology Data Storage Diagnostics & Research Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Instruments & Supplies
        Related Stock Lists: Medicine Biopharmaceutical Chronic Kidney Disease Clinical Medicine Dialysis Membrane Technology Phosphates Renal Dialysis Acid Acute Respiratory Distress Syndrome Adjunctive Therapy Animal Health Blood Plasma Blood Products Bypass Bypass Surgery Cac 40 Cancer Cardiopulmonary Bypass Cardiopulmonary Bypass Surgery
        Kidney Disease

        Kidney disease is a condition in which the kidneys are damaged and unable to filter waste and toxins from the blood. This can lead to a buildup of waste and toxins in the body, which can cause a variety of symptoms, including fatigue, nausea, loss of appetite, and swelling in the hands and feet. In severe cases, kidney disease can lead to kidney failure, which requires dialysis or a kidney transplant.

        Browse All Tags